Yong-Jun Huh
Chief Executive Officer at GREEN CROSS HOLDINGS CORPORATION
Net worth: 17 M $ as of 31/05/2024
Profile
Yong-Jun Huh is currently the Co-Chief Executive Officer, Director & VP at Green Cross Holdings Corp.
and a Director at Artiva Biotherapeutics, Inc. He previously worked as a Director at GREEN CROSS WellBeing Corp.
and as an Executive Vice President at Green Cross Corp.
Huh holds an MBA from the University of Wisconsin and an undergraduate degree from Yonsei University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/06/2024 | 1,367,454 ( 2.91% ) | 14 M $ | 31/05/2024 | |
| 31/12/2022 | 300,000 ( 1.69% ) | 2 M $ | 31/05/2024 | |
GC CELL CORPORATION
0.20% | 30/09/2023 | 31,000 ( 0.20% ) | 759 019 $ | 31/05/2024 |
Yong-Jun Huh active positions
| Companies | Position | Start |
|---|---|---|
| GREEN CROSS HOLDINGS CORPORATION | Chief Executive Officer | 01/03/2010 |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 01/09/2019 |
Former positions of Yong-Jun Huh
| Companies | Position | End |
|---|---|---|
| GC BIOPHARMA CORP. | Corporate Officer/Principal | - |
| GREEN CROSS WELLBEING CORPORATION | Director/Board Member | - |
Training of Yong-Jun Huh
| Yonsei University | Undergraduate Degree |
| University of Wisconsin | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GREEN CROSS HOLDINGS CORPORATION | Health Technology |
| GREEN CROSS WELLBEING CORPORATION | Health Technology |
| GC BIOPHARMA CORP. | Health Technology |
| Private companies | 1 |
|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Yong-Jun Huh
